Form 4: Verve Therapeutics Officer Joan Nickerson Reports Stock Transactions
SEC Form 4 Filing
Joan Nickerson, Chief Administrative Officer of Verve Therapeutics, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On April 1, 2025, Joan Nickerson, Chief Administrative Officer of Verve Therapeutics, settled 9,315 restricted stock units (RSUs) into common stock.
- These RSUs converted into common stock on a one-for-one basis.
- On April 2, 2025, Nickerson sold 2,777 shares of common stock at a price of $4.15 per share.
- The sale was executed under a pre-arranged automatic sale plan to cover withholding tax liabilities related to the vesting of the RSUs.
- Following these transactions, Nickerson directly owns 17,420 shares of Verve Therapeutics common stock.
- Nickerson also holds 6,630 and 18,000 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company officer, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.
Stakeholder Impact
- The transactions have a minimal impact on stakeholders as they are routine and related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| March 17, 2023 | Date of adoption of the durable automatic sale instruction plan. |
| February 14, 2023 | Date the reporting person was granted 13,260 RSUs pursuant to the Verve Therapeutics, Inc. 2021 Stock Incentive Plan. |
| February 14, 2024 | Date the reporting person was granted 24,000 RSUs pursuant to the Verve Therapeutics, Inc. 2021 Stock Incentive Plan. |
| April 1, 2025 | Date of RSU settlement and conversion to common stock. |
| April 2, 2025 | Date of common stock sale. |
| April 3, 2025 | Date of Form 4 filing. |
Keywords
Verve Therapeutics, Joan Nickerson, Form 4, Stock Transaction, Restricted Stock Units, Common Stock, Officer, VERV, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.